Sam R. Leno Appointed to Omnicare's Board of Directors
(Thomson Reuters ONE) -
CINCINNATI, May 24, 2012 - Omnicare, Inc. (NYSE:OCR), today announced the
appointment of Sam R. Leno to its Board of Directors and he will also become a
member of the Audit Committee.
Mr. Leno has more than 40 years of business experience with multinational
companies, the vast majority within the healthcare sector. He recently retired
as Executive Vice President and Chief Operations Officer at Boston Scientific,
where he was responsible for the finance, information systems, operations,
business development, strategy and restructuring functions. Mr. Leno previously
served as Boston Scientific's Executive Vice President, Finance and Information
Systems and Chief Financial Officer. Prior to joining Boston Scientific, he
served as Executive Vice President, Corporate Finance and Operations and Chief
Financial Officer at Zimmer Holdings, Inc. Mr. Leno has also held Chief
Financial Officer positions at Arrow Electronics, Inc., Corporate Express, Inc.,
and Coram Healthcare. Earlier in his career, he held a variety of senior
financial positions at Baxter International, Inc. and American Hospital Supply
Corporation. Mr. Leno served as a Lieutenant in the United States Navy and is a
Vietnam veteran. He currently serves on the Board of Directors and is Chairman
of the Audit Committee of Lantheus MI Holdings, Inc. He is also a member of the
Advisory Board of the Harvard Business School Healthcare Initiative. Mr. Leno
holds a B.S. Degree in Accounting and an MBA.
"We are pleased to welcome Sam to Omnicare's Board of Directors," said James D.
Shelton, Omnicare's Chairman of the Board. "Sam is a highly accomplished
executive who brings to the board a broad range of expertise and extensive
healthcare experience. We believe Omnicare's shareholders will benefit from his
finance and operational experience."
About Omnicare
Omnicare, Inc., a Fortune 400 company based in Cincinnati, Ohio, provides
comprehensive pharmaceutical services to patients and providers across North
America. As the market-leader in professional pharmacy, related consulting and
data management services for skilled nursing, assisted living and other chronic
care institutions, Omnicare leverages its unparalleled clinical insight into the
geriatric market along with some of the industry's most innovative technological
capabilities to the benefit of its long-term care customers. Omnicare also
provides key commercialization services for the bio-pharmaceutical industry and
end-of-life disease management through its Specialty Care Group. For more
information, visit www.omnicare.com.
Forward-looking Statements
In addition to historical information, this report contains certain statements
that constitute "forward-looking statements" within the meaning of the Private
Securities Litigation Reform Act of 1995. These forward-looking statements
include, but are not limited to, all statements regarding the intent, belief or
current expectations regarding the matters discussed or incorporated by
reference in this document (including statements as to "beliefs,"
"expectations," "anticipations," "intentions" or similar words) and all
statements which are not statements of historical fact. Such forward-looking
statements, together with other statements that are not historical, are based on
management's current expectations and involve known and unknown risks,
uncertainties, contingencies and other factors that could cause results,
performance or achievements to differ materially from those stated. The most
significant of these risks and uncertainties are described in the Company's Form
10-K, Form 10-Q and Form 8-K reports filed with the Securities and Exchange
Commission. Should one or more of these risks or uncertainties materialize or
should underlying assumptions prove incorrect, the Company's actual results,
performance or achievements could differ materially from those expressed in, or
implied by, such forward-looking statements. Readers are cautioned not to place
undue reliance on these forward-looking statements, which speak only as of the
date hereof. Except as otherwise required by law, the Company does not undertake
any obligation to publicly release any revisions to these forward-looking
statements to reflect events or circumstances after the date hereof or to
reflect the occurrence of unanticipated events.
# # #
Contact:
Media:
Tim Canning
(859) 392-7444
tim.canning(at)omnicare.com
Investors:
Patrick C. Lee
(859) 392-3444
patrick.lee(at)omnicare.com
This announcement is distributed by Thomson Reuters on behalf of
Thomson Reuters clients. The owner of this announcement warrants that:
(i) the releases contained herein are protected by copyright and
other applicable laws; and
(ii) they are solely responsible for the content, accuracy and
originality of the information contained therein.
Source: Omnicare via Thomson Reuters ONE
[HUG#1614512]
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: hugin
" alt="Globex Announces $3,150,000 Private PlacementDatum: 24.05.2012 - 15:16 Uhr
Sprache: Deutsch
News-ID 149882
Anzahl Zeichen: 5582
contact information:
Town:
Covington, KY
Kategorie:
Business News
Diese Pressemitteilung wurde bisher 253 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Sam R. Leno Appointed to Omnicare's Board of Directors"
steht unter der journalistisch-redaktionellen Verantwortung von
Omnicare (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).
